Dynavax Technologies Corp (NASDAQ:DVAX)
CAPS Rating:
A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory.
RSS Headlines
Fool UK
Recs
Expect the huge gap to get filled over the next few days and a slow rise back to 6 over the next couple of months.